Estimation of sleep improvement after the administration of OAB drugs and ramelteon using a contactless biomotion sensor

Estimation of sleep improvement after the administration of OAB drugs and ramelteon using a contactless biomotion sensor - Estimation of sleep improvement after the administration of OAB drugs and ramelteon using a contactless biomotion sensor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025441

Enrollment

Registered

2016-12-27

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OAB with insomnia

Interventions

The contactless biomotion sensor, N-QOL, IPSS, OABSS before and after drug treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: OAB nocturia 2 and more a night insomnia

Exclusion criteria

Exclusion criteria: 1. PVR >50mL 2. active urinary tract infection 3. malignant tumor of lower urinary tract 4. surgery for lower urinary tract in the past 3 months

Design outcomes

Primary

Measure	Time frame
hours of undisturbed sleep	—

Countries

Japan

Contacts

Public ContactKazumasa Torimoto

Nara Medical University Urology

torimoto@naramed-u.ac.jp0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026